Cellebrite Other Liab vs Cash And Short Term Investments Analysis

CLBT Stock

USD 18.56 0.06 0.32%

Cellebrite financial indicator trend analysis is way more than just evaluating Cellebrite DI prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cellebrite DI is a good investment. Please check the relationship between Cellebrite Other Liab and its Cash And Short Term Investments accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellebrite DI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Other Liab vs Cash And Short Term Investments

Other Liab vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cellebrite DI Other Liab account and Cash And Short Term Investments. At this time, the significance of the direction appears to have weak relationship.

The correlation between Cellebrite's Other Liab and Cash And Short Term Investments is 0.36. Overlapping area represents the amount of variation of Other Liab that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Cellebrite DI, assuming nothing else is changed. The correlation between historical values of Cellebrite's Other Liab and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Liab of Cellebrite DI are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Other Liab i.e., Cellebrite's Other Liab and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.36

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Other Liab

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Cellebrite DI balance sheet. This account contains Cellebrite investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Cellebrite DI fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most indicators from Cellebrite's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cellebrite DI current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellebrite DI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

At this time, Cellebrite's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 4.7 B in 2025, whereas Tax Provision is likely to drop slightly above 4 M in 2025.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	9.2M	10.0M	10.6M	8.6M
Interest Income	1.6M	8.9M	10.2M	18.5M

Depreciation And Amortization Interest Income

Cellebrite fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		0.84	0.96	0.67	0.61	-0.21	0.81	0.97	-0.85	-0.43	0.76	0.9	0.91	0.84	-0.69	0.93	0.88	0.27	0.58	-0.1	0.84	0.9	0.73	0.75	-0.26	0.96
Other Current Liab	0.84		0.94	0.4	0.85	-0.57	0.77	0.91	-0.85	-0.19	0.59	0.89	0.9	0.67	-0.31	0.64	0.98	-0.13	0.12	0.15	0.86	0.95	0.5	0.88	-0.52	0.79
Total Current Liabilities	0.96	0.94		0.53	0.77	-0.41	0.88	1.0	-0.87	-0.26	0.68	0.93	0.98	0.83	-0.54	0.79	0.97	0.15	0.33	0.07	0.93	0.98	0.61	0.88	-0.4	0.92
Total Stockholder Equity	0.67	0.4	0.53		0.12	0.23	0.45	0.54	-0.55	-0.83	0.93	0.44	0.46	0.36	-0.68	0.75	0.47	0.44	0.76	-0.75	0.41	0.42	0.97	0.21	0.11	0.53
Other Liab	0.61	0.85	0.77	0.12		-0.88	0.6	0.73	-0.71	-0.03	0.42	0.74	0.76	0.53	-0.12	0.36	0.79	-0.03	-0.18	0.37	0.74	0.77	0.29	0.84	-0.84	0.62
Net Tangible Assets	-0.21	-0.57	-0.41	0.23	-0.88		-0.17	-0.35	0.45	-0.1	-0.12	-0.47	-0.38	-0.18	-0.19	-0.01	-0.44	0.27	0.46	-0.51	-0.35	-0.41	0.02	-0.59	0.96	-0.27
Property Plant And Equipment Net	0.81	0.77	0.88	0.45	0.6	-0.17		0.9	-0.6	0.03	0.49	0.67	0.95	0.75	-0.41	0.57	0.89	0.34	0.23	0.03	0.98	0.9	0.43	0.76	-0.1	0.73
Current Deferred Revenue	0.97	0.91	1.0	0.54	0.73	-0.35	0.9		-0.85	-0.24	0.66	0.92	0.98	0.87	-0.58	0.8	0.95	0.21	0.36	0.07	0.94	0.98	0.6	0.87	-0.35	0.93
Net Debt	-0.85	-0.85	-0.87	-0.55	-0.71	0.45	-0.6	-0.85		0.5	-0.75	-0.96	-0.78	-0.79	0.69	-0.77	-0.82	0.02	-0.26	-0.1	-0.7	-0.84	-0.69	-0.86	0.56	-0.85
Retained Earnings	-0.43	-0.19	-0.26	-0.83	-0.03	-0.1	0.03	-0.24	0.5		-0.84	-0.36	-0.1	-0.16	0.64	-0.65	-0.15	-0.23	-0.69	0.66	0.01	-0.11	-0.88	-0.02	0.11	-0.37
Accounts Payable	0.76	0.59	0.68	0.93	0.42	-0.12	0.49	0.66	-0.75	-0.84		0.64	0.58	0.47	-0.69	0.79	0.6	0.38	0.63	-0.55	0.51	0.56	0.99	0.43	-0.26	0.66
Cash	0.9	0.89	0.93	0.44	0.74	-0.47	0.67	0.92	-0.96	-0.36	0.64		0.86	0.87	-0.64	0.8	0.86	-0.02	0.28	0.22	0.77	0.91	0.58	0.9	-0.54	0.94
Non Current Assets Total	0.91	0.9	0.98	0.46	0.76	-0.38	0.95	0.98	-0.78	-0.1	0.58	0.86		0.84	-0.48	0.69	0.96	0.23	0.25	0.13	0.99	0.98	0.51	0.89	-0.34	0.87
Non Currrent Assets Other	0.84	0.67	0.83	0.36	0.53	-0.18	0.75	0.87	-0.79	-0.16	0.47	0.87	0.84		-0.77	0.74	0.72	0.28	0.32	0.3	0.79	0.83	0.43	0.84	-0.28	0.91
Other Assets	-0.69	-0.31	-0.54	-0.68	-0.12	-0.19	-0.41	-0.58	0.69	0.64	-0.69	-0.64	-0.48	-0.77		-0.8	-0.37	-0.46	-0.64	0.18	-0.4	-0.47	-0.72	-0.45	0.03	-0.73
Cash And Short Term Investments	0.93	0.64	0.79	0.75	0.36	-0.01	0.57	0.8	-0.77	-0.65	0.79	0.8	0.69	0.74	-0.8		0.65	0.31	0.8	-0.27	0.58	0.69	0.8	0.52	-0.13	0.91
Net Receivables	0.88	0.98	0.97	0.47	0.79	-0.44	0.89	0.95	-0.82	-0.15	0.6	0.86	0.96	0.72	-0.37	0.65		0.01	0.17	0.09	0.94	0.98	0.53	0.88	-0.39	0.8
Common Stock Shares Outstanding	0.27	-0.13	0.15	0.44	-0.03	0.27	0.34	0.21	0.02	-0.23	0.38	-0.02	0.23	0.28	-0.46	0.31	0.01		0.51	-0.39	0.26	0.05	0.38	-0.04	0.17	0.26
Short Term Investments	0.58	0.12	0.33	0.76	-0.18	0.46	0.23	0.36	-0.26	-0.69	0.63	0.28	0.25	0.32	-0.64	0.8	0.17	0.51		-0.66	0.15	0.19	0.7	-0.08	0.34	0.52
Non Current Liabilities Total	-0.1	0.15	0.07	-0.75	0.37	-0.51	0.03	0.07	-0.1	0.66	-0.55	0.22	0.13	0.3	0.18	-0.27	0.09	-0.39	-0.66		0.14	0.19	-0.63	0.46	-0.46	0.09
Inventory	0.84	0.86	0.93	0.41	0.74	-0.35	0.98	0.94	-0.7	0.01	0.51	0.77	0.99	0.79	-0.4	0.58	0.94	0.26	0.15	0.14		0.95	0.43	0.86	-0.29	0.78
Other Current Assets	0.9	0.95	0.98	0.42	0.77	-0.41	0.9	0.98	-0.84	-0.11	0.56	0.91	0.98	0.83	-0.47	0.69	0.98	0.05	0.19	0.19	0.95		0.49	0.92	-0.38	0.87
Other Stockholder Equity	0.73	0.5	0.61	0.97	0.29	0.02	0.43	0.6	-0.69	-0.88	0.99	0.58	0.51	0.43	-0.72	0.8	0.53	0.38	0.7	-0.63	0.43	0.49		0.33	-0.13	0.61
Total Liab	0.75	0.88	0.88	0.21	0.84	-0.59	0.76	0.87	-0.86	-0.02	0.43	0.9	0.89	0.84	-0.45	0.52	0.88	-0.04	-0.08	0.46	0.86	0.92	0.33		-0.6	0.79
Net Invested Capital	-0.26	-0.52	-0.4	0.11	-0.84	0.96	-0.1	-0.35	0.56	0.11	-0.26	-0.54	-0.34	-0.28	0.03	-0.13	-0.39	0.17	0.34	-0.46	-0.29	-0.38	-0.13	-0.6		-0.35
Property Plant And Equipment Gross	0.96	0.79	0.92	0.53	0.62	-0.27	0.73	0.93	-0.85	-0.37	0.66	0.94	0.87	0.91	-0.73	0.91	0.8	0.26	0.52	0.09	0.78	0.87	0.61	0.79	-0.35

Click cells to compare fundamentals

Cellebrite Account Relationship Matchups

Cellebrite fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	364.4M	339.8M	403.3M	532.9M	690.6M	478.7M
Other Current Liab	41.9M	45.1M	42.0M	43.2M	49.6M	43.2M
Total Current Liabilities	159.4M	186.6M	207.8M	253.8M	295.5M	220.4M
Total Stockholder Equity	63.8M	(73.3M)	73.9M	34.2M	336.0M	352.8M
Property Plant And Equipment Net	16.1M	16.8M	32.9M	30.2M	27.6M	25.4M
Current Deferred Revenue	106.1M	123.0M	152.7M	196.6M	217.0M	158.6M
Net Debt	(128.7M)	(146.0M)	(72.3M)	(175.4M)	(180.7M)	(189.7M)
Retained Earnings	28.3M	78.4M	199.2M	118.1M	(164.9M)	(156.6M)
Accounts Payable	4.7M	9.5M	4.6M	8.3M	74.4M	78.1M
Cash	128.7M	146.0M	87.6M	189.5M	191.7M	150.3M
Non Current Assets Total	40.1M	66.6M	107.4M	123.9M	123.0M	87.9M
Non Currrent Assets Other	565K	2.0M	1.7M	12.9M	7.7M	4.6M
Other Assets	7.9M	11.8M	14.2M	(13.1M)	(11.8M)	(11.2M)
Cash And Short Term Investments	237.6M	181.6M	183.6M	302.9M	447.2M	284.8M
Net Receivables	66.3M	67.5M	78.8M	77.3M	82.4M	76.3M
Common Stock Shares Outstanding	123.7M	161.5M	195.4M	190.2M	209.5M	195.7M
Short Term Investments	108.9M	35.6M	96.0M	113.4M	255.6M	134.4M
Liabilities And Stockholders Equity	364.4M	339.8M	403.3M	532.9M	690.6M	478.7M
Non Current Liabilities Total	141.2M	226.6M	121.7M	244.8M	59.0M	56.1M
Inventory	4.8M	6.5M	10.2M	9.9M	8.9M	8.1M
Other Current Assets	15.6M	16.8M	23.4M	32.0M	29.1M	21.7M
Other Stockholder Equity	(67.1M)	(153.2M)	(125.7M)	(85.0M)	498.8M	523.7M
Total Liab	300.6M	413.1M	329.4M	498.7M	354.5M	388.3M
Net Invested Capital	63.8M	(73.3M)	73.9M	34.2M	30.8M	25.2M
Property Plant And Equipment Gross	32.8M	38.2M	32.9M	63.4M	72.9M	42.8M
Total Current Assets	324.3M	273.2M	295.9M	422.1M	567.6M	393.2M
Accumulated Other Comprehensive Income	1.3M	1.4M	331K	1.1M	2.1M	1.3M
Non Current Liabilities Other	6.2M	133.3M	49.1M	134.5M	154.6M	162.4M
Net Working Capital	164.9M	86.6M	88.2M	168.3M	151.4M	107.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Cellebrite Stock Analysis

When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC